Regado Biosciences Announces Clinical Hold Of REGULATE-PCI Trial Following Voluntary Halt Of Trial By Regado

By: via Benzinga
Regado Biosciences, Inc., (NASDAQ: RGDO) today announced that, further to their decision to voluntarily pause enrollment in their ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.